key: cord-0926246-cwaq1jb0 authors: Ballas, Zuhair K. title: 2020: The year in review date: 2020-12-25 journal: J Allergy Clin Immunol DOI: 10.1016/j.jaci.2020.12.632 sha: 447c928fd745c35a172f9cba4c646b460e17bc85 doc_id: 926246 cord_uid: cwaq1jb0 nan The year 2020, to state the obvious, was a year like no other in recent memory. Norms were turned upside down in all aspects of our society, professions, and daily life. This impacted the journal's priorities, which shifted temporarily to focusing on all things coronavirus disease 2019 (COVID-19) while not neglecting our core mission of promoting the specialty. We had issued a call for evidence-based articles addressing various aspects of COVID-19 and promised expedited reviews. We had an outstanding response with a large volume of submissions, which meant we had to overtax our reviewers and our editorial staff. Our reviewers rose to the occasion and were able to render insightful, thoughtful, and timely reviews. To those reviewers who went above and beyond, you have our heartfelt thanks and appreciation and I am sure our authors will join me in extending a big Thank You. Given that this was the year of COVID-19, it was not surprising that most of our most cited and most downloaded articles in 2020 were related to the novel coronavirus. As listed in Table I, 7 of the top 10 downloaded articles were COVID-related. Similarly, 8 of the top 10 cited articles were COVID-related (Table II) . In an effort to avoid overlooking some of the most impactful articles across the specialty that were published in the Journal of Allergy and Clinical Immunology (JACI) in 2020, the editors selected the top 10 articles that they thought will have an immediate or future impact on our discipline. The top choices are presented in Table III (arranged chronoligcally) . A major highlight of 2020 for JACI was the publication of the ''2020 Focused Updates to the Asthma Management Guidelines,'' which were in the December 2020 issue. 1 These guidelines were accompanied by a rostrum by Israel 2 and another rostrum by Szefler. 3 In addition, we had 3 editorials addressing specific aspects of the guidelines. [4] [5] [6] In 2020 we also saw the sunsetting of the Letter to the Editor format. As of July 1, 2020, JACI no longer accepts Letters to the Editor. These have been replaced by a ''Brief Report'' format. The rationale for this switch and the detailed description of the Brief Report format were detailed in a previous editorial. 7 We are also introducing a new feature in 2021 titled ''The Last Page,'' which will feature a graphic display on the last page of the print issue. This is being introduced because we have received many interesting submissions of graphic displays that may not fit in any of our standard formats but may be of interest to our readers. The specifics are as follows: ''The Last Page'' is dedicated to various graphic displays that relate to the scope of JACI. The content must not occupy more than 1 print page, and it will be citable with a DOI. Other formatting information includes the following: 1. Title page: a. Title-up to 12 words. b. Authors-no more than 3 and must meet the standard JACI criteria for authorship. c. Corresponding author (mailing address, phone number, and email address). d. Funding statement. e. Disclosure statement (must include ALL authors). 2. The graphic display can be accompanied by no more than 200 words of text explaining the subject of the display. 3. One to 3 references may be used. 4. No Online Repository is allowed. 5. The image must be supplied in high resolution and adhere to our usual technical requirements for graphical displays. We look forward to another year of continued service to our authors, our readers, and our specialty as we look forward to returning to pre-COVID normal. 2020 Focused Updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group Implementing the guidelines: what do you do when the rubber hits the road? Update on the NAEPPCC Asthma Guidelines: the wait is over, or is it? Updated Asthma Guidelines: clinical utility of fractional exhaled nitric oxide (Feno) in asthma management Updated Asthma Guidelines: indoor allergen reduction Updated Asthma Guidelines: allergen immunotherapy Update on JACI's evolution